Company / Revenue per Share
Pyxis Oncology, Inc. Revenue per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.27
FY2025
5-year range
$0.27 / $0.36
FY2024-FY2025
Trend
-25.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
0.27 in FY2025.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 25.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.27 | -25.4% |
| FY2024 | $0.36 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026